Retatrutide vs Tirzepatide
One activates three receptors, the other two. Here is the research difference, plain and simple.
What is the difference
Retatrutide and tirzepatide are the two most-discussed metabolic peptides in current research. Both originate from Eli Lilly, both target overlapping receptor systems — but retatrutide adds a third receptor that tirzepatide does not touch. This page separates what the published preclinical and trial data say from what it does not.
| Property | Retatrutide | Tirzepatide |
|---|---|---|
| Mechanism | Triple agonist: GLP-1 + GIP + glucagon | Dual agonist: GLP-1 + GIP |
| Developer | Eli Lilly (Phase 2/3 trials) | Eli Lilly (approved in branded medicines) |
| Common formats | 15 mg lyophilized powder | 15 mg lyophilized powder |
| Research focus | Energy expenditure + metabolic signalling | Glucose regulation + appetite signalling |
| Key differentiator | Glucagon receptor — the third arm | Established clinical track record |
| VND price (this catalog) | 2,200,000 VND | 1,900,000 VND |
Bottom line
These are two distinct research materials with different receptor profiles. One is not a 'better' version of the other — they address different research questions. Both are available in this catalog: check availability for your specific research need.
Ask about Retatrutide or Tirzepatide
Format, price and timing confirmed before payment. Free swabs + syringe with every order.
Common questions
Which of these peptides is better for research?
Neither is "better" — Retatrutide and Tirzepatide address different research questions through different mechanisms. The choice depends on the research protocol.
Can I order both peptides from this catalog?
Yes. Retatrutide and Tirzepatide are listed as separate items. 2+ peptides = free bacteriostatic water 10 ml. Price and availability confirmed before payment.
Do I need a separate inquiry for each peptide?
No. You can ask about both in one Telegram message. Mention the names and formats — the manager will confirm availability, total and timing.